Loading…
← CockpitCompetitor Analysis › CARERATING.NS CARE Ratings LtdOpen in the cockpit ↗

CARE Ratings LtdCARERATING.NSCompetitor analysis, valuation and peers

India · INR·Financials›Financial Publishing/Services
Momentum weak 37
Mkt cap
$514M
US dollars, full cap
Free float
87%
of shares outstanding
$/day
$589,475
20-day average traded
Fwd P/E
80.2×
forward earnings
ROIC−WACC
n/a
WACC 11.1%
Hurdle
n/a
no reverse DCF
Next earnings
65 days
22 Jan 2027
Close · INR₹1,596
1D+1.8%
1W+0.1%
1M-1.2%
3M-7.5%
6M-9.1%
YTD-0.2%
1Y+5.0%
ATR %2.6%
Beta0.72
52w lowhigh13.2% off high

What CARE Ratings does

Employees: 648

CARE Ratings at a glance

Size CARE Ratings (CARERATING.NS) is an India Financials company (Financial Publishing/Services) with a market value of $514M, the 834th largest of 1,066 India companies the cockpit tracks. Shares closed at ₹1,596 on 18 Nov 2026.

Performance Over six months the shares fell 9.1%, against -8.2% for the median peer and +3.8% for the India market (cap-weighted) — 4th highest of 7 in its peer set.

Growth Revenue grew 18.9% over the last twelve months (peer median +3.4%); the operating margin is 39.7% (peer median 27.0%).

Valuation It trades at 80.2× forward earnings against a peer median of 17.3× (most expensive of 5).

Next results Next results expected around 22 Jan 2027 (exchange calendar; dates can move).

Relative performance

909510021 May 202621 Aug 202618 Nov 2026CARERATING.NS 93Peer median 91
Six months, rebased to 100: CARE Ratings against the median of its 6 peers (local-currency closes).

CARE Ratings financials

Reported figures in INR; fiscal year ends 2026-03-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
Revenue₹5.19B₹4.73B₹4.02B₹3.32B₹2.79B
Revenue growth—+18%+21%+19%—
Gross profit₹2.06B₹2.40B₹1.98B₹1.49B₹1.32B
EBITDA₹2.21B₹2.01B₹1.58B₹1.14B₹1.07B
Net income₹1.93B₹1.71B₹1.37B₹1.01B₹835M
Free cash flown/a₹2.44B₹1.56B₹1.22B₹895M
Capital expendituren/a₹83.0M₹147M₹91.7M₹115M
Total debt₹241M₹262M₹238M₹196M₹175M

Quarterly statements and history in the cockpit →

CARE Ratings competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-20%-10%0%+10%+20%0%+5%ICRAENENTO030190034950034310TCUCARERATING.NS6-month return →1-month return →
Up and to the right = strong over both horizons. CARE Ratings is the large dot.

Fundamentals: revenue growth against valuation

0%+10%+20%+30%25×50×75×ICRAENENTO030190TCUCARERATING.NSRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. CARE Ratings is the large dot.

CARE Ratings competitors and peer comparison

How CARE Ratings compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

CARE Ratings against its 6 peers (data as of 18 Nov 2026)
MeasureCARERATING.NSPeer medianRank in peer set
1-month return-1.2%-1.6%4th highest of 7
6-month return-9.1%-8.2%4th highest of 7
Distance from 52-week high-13.2%-18.3%3rd highest of 7
Revenue growth (TTM)+18.9%+3.4%2nd highest of 7
Operating margin39.7%27.0%2nd highest of 7
Forward P/E80.2×17.3×most expensive of 5

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
CARE Ratings CARERATING.NSIndia$514M-9%+19%40%80.2×n/an/a
ICRA ICRA.NSIndia$460M-17%+31%30%19.8×n/an/a
Enento ENENTO.HEFinland$424M+6%+4%24%17.1×n/an/a
NICE Information Service 030190.KSSouth Korea$734M+19%+8%18%11.0×n/an/a
Korea Ratings 034950.KSSouth Korea$335M-6%+1%31%n/an/an/a
NICE 034310.KSSouth Korea$312M-10%+3%6%n/an/an/a
Credit Bureau Asia TCU.SISingapore$172M-19%+1%47%17.5×n/an/a

Questions

Which companies are CARE Ratings's closest peers?
The cockpit's peer set: ICRA (ICRA.NS), Enento (ENENTO.HE), NICE Information Service (030190.KS), Korea Ratings (034950.KS), NICE (034310.KS), Credit Bureau Asia (TCU.SI).
Is CARE Ratings expensive compared with its peers?
On forward p/e it trades at 80.2× against a peer median of 17.3×, most expensive of 5 in its peer set.
How has CARE Ratings stock performed?
Over six months to 18 Nov 2026 the shares returned -9.1% against -8.2% for the median peer; over one year +5.0%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.